Validation of a histologic scoring index for C3 glomerulopathy

F Caravaca-Fontan, H Trujillo, M Alonso… - American Journal of …, 2021 - Elsevier
C3 glomerulopathy histologic index and the risk of kidney failure in a multicenter cohort of 111
patients with C3 glomerulopathy … previously proposed C3 glomerulopathy histologic index …

[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …

THJ Goodship, HT Cook, F Fakhouri, FC Fervenza… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement
plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 …

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

F Caravaca-Fontán, M Díaz-Encarnación… - Nephrology Dialysis …, 2022 - academic.oup.com
… For the assessment of the discriminative capability of the longitudinal change in proteinuria
in C3 glomerulopathy, we focused on the time interval between 6 months and 5 years, and a …

Remissions and progression of C3 glomerulopathy

AV Karunnaya, VA Dobronravov - Terapevticheskii arkhiv, 2022 - ter-arkhiv.ru
… To analyze the outcomes of C3-glomerulopathy (C3-GP) and … patients with newly diagnosed
C3-GP (with primary C3-GP – … morphological presentation of C3 glomerulopathy: a single-…

[HTML][HTML] … activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: core curriculum 2015

M Noris, G Remuzzi - American Journal of Kidney Diseases, 2015 - Elsevier
… /C3 glomerulopathy (C3G). … C3 glomerulopathies. Mutations in the factor H (FH) gene
causing very low FH levels or impaired FH cofactor activity, or C3 nephritic factor (C3NeF) and C3

C3 glomerulopathy: A new complement-based entity

A De Lorenzo, S Tallón, B Hernández-Sevillano… - Revista Clínica …, 2014 - Elsevier
… Direct immunofluorescence stainings will be positive to immunoglobulins, mainly IgG and
IgM, as well as C3 and/or C1. C3 glomerulopathy is produced by dysfunction of the alternative …

[HTML][HTML] Utility of immunohistochemistry with C3d in C3 glomerulopathy

MLH Snijders, BJ Van de Wall-Neecke, DA Hesselink… - Modern Pathology, 2020 - Elsevier
C3 glomerulopathy as an ancillary diagnostic tool. All biopsies from patients diagnosed with
C3 glomerulopathy in … included (n = 14; 10 C3 glomerulonephritis, 4 dense deposit disease). …

Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN

MC Marinozzi, LT Roumenina, S Chauvet… - Journal of the …, 2017 - journals.lww.com
… , such as C3 glomerulopathies (C3Gs). Complement is frequently overactivated by C3
nephritic factors (C3NeFs). C3NeFs bind to a neoepitope on the AP C3 convertase, C3bBb, …

Retinal disease in the C3 glomerulopathies and the risk of impaired vision

J Savige, L Amos, F Ierino, HG Mack… - Ophthalmic …, 2016 - Taylor & Francis
… Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound …
Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, …

Recurrent C3 glomerulopathy after kidney transplantation

S Obata, PASV de Castro, LV Riella, P Cravedi - Transplantation Reviews, 2024 - Elsevier
C3 glomerulopathy (C3G) is a rare glomerular disease driven by complement
dysregulation with high post-transplantation recurrence rates. Its treatment is mainly based on …